This bill increases federal funding for sickle cell disease programs from $4.455 million annually (2019-2023) to $8.205 million annually (2025-2029). It revises existing law to expand the focus from "prevention and treatment of sickle cell disease" to specifically include "treatment of sickle cell disease and the prevention and treatment of complications." These changes directly affect patients with sickle cell disease and related blood disorders by prioritizing care for complications and increasing available resources. The bill amends Section 1106(b) of the Public Health Service Act to implement these funding and policy adjustments.
The End the Vaccine Carveout Act changes the National Vaccine Injury Compensation Program (NVICP) to allow individuals to sue vaccine manufacturers or administrators directly in court for vaccine-related injuries or deaths, without first needing to file a claim under the NVICP. It removes time limits for filing NVICP claims and repeals rules that previously let people choose between the program and a lawsuit for the same injury. The bill also specifically excludes COVID-19 vaccines from the definition of "covered countermeasure," meaning they are no longer protected by the same emergency liability shield that applied to other pandemic vaccines. This affects vaccine manufacturers, providers, and individuals who experience vaccine-related harm, shifting liability from the NVICP to the court system for most cases.
The ETHIC Act (HR 3269) limits how many patents pharmaceutical companies can assert in lawsuits against generic drug and biosimilar manufacturers. Specifically, it prohibits a company from claiming more than one patent per "Patent Group" (commonly owned patents linked through disclaimers) in an infringement case involving a generic drug applicant or biosimilar product. This directly affects generic drug makers (under FDA's 505(b)(2) or 505(j) pathways) and biosimilar developers (under the Public Health Service Act), reducing the ability of brand-name companies to use stacked patents to delay competition. The law applies to applications submitted after its enactment date.
The Nurse Corps Tax Parity Act of 2025 ensures that payments to nurses in the Public Health Service Nurse Corps under section 846 of the Public Health Service Act are treated as tax-exempt, aligning with existing tax treatment for similar payments under section 338B(g). This change means nurses receiving these specific payments - such as scholarships or loan repayment assistance - will not owe income tax on them. The bill amends two sections of the Internal Revenue Code to explicitly include section 846 in the tax-exempt provisions. These changes apply to payments received after the bill becomes law.
Affordable and Safe Prescription Drug Importation Act of 2025 This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported. Current law allows the Department of Health and Human Services (HHS) to authorize importation of certain eligible prescription drugs from Canada if HHS certifies that doing so would pose no additional risk to public health and safety, among other requirements. HHS long declined to make the requisite certification, citing safety concerns (e.g., contamination, counterfeiting), but ultimately made the certification in 2020 and has since approved one state plan to import drugs. The bill removes the certification requirement and requires HHS to issue regulations that permit importation of qualifying prescription drugs from the United Kingdom, Switzerland, and member states of the European Union, in addition to Canada. After one year, if HHS determines that importation of drugs from these countries has been conducted safely, HHS may authorize importation from other countries that meet certain requirements. The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. Further, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. Finally, the bill imposes criminal penalties for websites that sell counterfeit drugs or dispense drugs without a required prescription.
HR 2884 establishes a National Center on Antiracism and Health within the CDC to address structural racism as a public health crisis. The center will research how racism impacts health outcomes, collect disaggregated data by race, ethnicity, and other factors, and develop antiracist interventions for public health systems. It requires CDC to create regional centers in minority communities, build a public data clearinghouse, and train health professionals on racism's health effects. The bill also directs the CDC to research police violence's public health impacts and develop prevention strategies, requiring annual reports to Congress on these efforts.
The Protecting Young Minds Online Act requires the Center for Mental Health Services to develop and implement a strategy helping local communities address how new technologies, such as social media, affect children's mental health. This strategy will provide communities with practical resources and guidance to support children's well-being in digital environments. The bill amends the Public Health Service Act to add this specific requirement for the Center. It directly affects the Center for Mental Health Services (which must create the strategy) and local communities (which will use the strategy to address technology-related mental health challenges for children).
The Disaster Relief Medicaid Act creates a new Medicaid program to provide medical assistance to individuals affected by disasters. It establishes a "relief coverage period" of two years beginning when a disaster is declared, during which survivors can receive Medicaid benefits without meeting standard income requirements. The bill simplifies the application process by removing documentation requirements and provides 100% federal funding for these services. It includes special provisions for pregnant individuals, those with pending applications, and individuals requiring home and community-based services. The program applies to individuals who were residents of the disaster area or lost employment due to the disaster, with benefits available to survivors regardless of their home state.
HR 479, the Healthy SNAP Act of 2025, revises which foods are eligible for purchase using Supplemental Nutrition Assistance Program (SNAP) benefits. It prohibits SNAP benefits from being used for alcoholic beverages, tobacco, soft drinks, candy, ice cream, and prepared desserts like cakes or pies. The bill requires the Secretary of Agriculture to establish regulations within 180 days designating specific foods that contain nutrients lacking in U.S. diets, promote health based on nutrition science, and align with cultural eating patterns, while limiting fat, sugar, and salt. The Secretary must also review and update these designations at least every five years to reflect current science, and states may substitute culturally appropriate foods if nutritionally equivalent. This directly affects SNAP recipients and the program's food eligibility rules.
The Family Vaccine Protection Act makes the Advisory Committee on Immunization Practices (ACIP) an official part of federal law, requiring it to provide vaccine recommendations based on strong scientific evidence. It mandates that the CDC Director must adopt ACIP's recommendations unless they don't meet the evidence standard, and if not adopted, the CDC must explain its decision and notify Congress within 48 hours. The bill establishes procedures for ACIP to review new vaccines within 90 days of licensure and to consider breakthrough therapies or public health emergencies. This act aims to strengthen transparency and evidence-based decision-making in vaccine recommendations for the public health system. It affects the CDC, ACIP, and Congress through formalized processes for vaccine policy development.
